Biotech

All Articles

Lilly messages more favorable data on its weekly blood insulin prospect

.On the heels of an FDA being rejected for its own main rival Novo Nordisk, Eli Lilly is pulling ahe...

IN 8bio standstills period 2 trial, gives up half of staff

.Just a few months after application the very first individual in a phase 2 test for recently detect...

Lilly, Haya ink $1B biobuck obesity pact to look black genome

.Eli Lilly's search for excessive weight targets has led it to the black genome. The Big Pharma has ...

ArsenalBio increases $325M, turns far from former lead possession

.Collection Biosciences is proceeding up. The tissue treatment provider has actually added on $325 t...

Lilly- supported weight loss biotech files IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has actually ...

Aelis' cannabis usage medicine flunks stage 2b, driving Indivior to reassess $100M alternative

.Aelis Farma's chances of safeguarding a fast, positive choice on a $one hundred million possibility...

ProKidney halts period 3 test not needed to have for cell therapy permission

.ProKidney has actually ceased among a pair of phase 3 trials for its own tissue treatment for kidne...

Vaxcyte climbs on 'remarkable' 31-valent PCV win against Pfizer

.Vaxcyte introduced what professionals called "impressive" period 1/2 records for its 31-valent pneu...

Recursion's mind condition test shows little proof of efficiency

.Recursion has discovered with a very early examination of its own tech-enabled technique to medicat...

Acepodia, Pfizer click on with each other for chemistry-based tissue therapy

.Call it an instance of great chemistry: Acepodia, a biotech based upon Nobel Prize-winning science,...